These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33517829)

  • 1. The role of social determinants in timely herpes zoster vaccination among older American adults.
    Shuvo S; Hagemann T; Hohmeier K; Chiu CY; Ramachandran S; Gatwood J
    Hum Vaccin Immunother; 2021 Jul; 17(7):2043-2049. PubMed ID: 33517829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social determinants of health and adult influenza vaccination: a nationwide claims analysis.
    Gatwood J; Ramachandran S; Shuvo SA; Behal M; Hagemann T; Hohmeier KC; Chiu CY
    J Manag Care Spec Pharm; 2022 Feb; 28(2):196-205. PubMed ID: 35098752
    [No Abstract]   [Full Text] [Related]  

  • 3. Pneumococcal vaccination in older adults: An initial analysis of social determinants of health and vaccine uptake.
    Gatwood J; Shuvo S; Hohmeier KC; Hagemann T; Chiu CY; Tong R; Ramachandran S
    Vaccine; 2020 Jul; 38(35):5607-5617. PubMed ID: 32654903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.
    Zhang J; Xie F; Delzell E; Chen L; Winthrop KL; Lewis JD; Saag KG; Baddley JW; Curtis JR
    JAMA; 2012 Jul; 308(1):43-9. PubMed ID: 22760290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes Zoster Vaccine Coverage in Older Adults in the U.S., 2007-2013.
    Zhang D; Johnson K; Newransky C; Acosta CJ
    Am J Prev Med; 2017 Jan; 52(1):e17-e23. PubMed ID: 28340974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower dementia risk in patients vaccinated against herpes zoster.
    Scherrer J; Salas J; Jacobs C; Wiemken T
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment.
    Patterson BJ; Myers K; Stewart A; Mange B; Hillson EM; Poulos C
    Expert Rev Vaccines; 2021 Jun; 20(6):729-741. PubMed ID: 33902368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older.
    Izurieta HS; Wernecke M; Kelman J; Wong S; Forshee R; Pratt D; Lu Y; Sun Q; Jankosky C; Krause P; Worrall C; MaCurdy T; Harpaz R
    Clin Infect Dis; 2017 Mar; 64(6):785-793. PubMed ID: 28362955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.
    Zhang J; Delzell E; Xie F; Baddley JW; Spettell C; McMahan RM; Fernandes J; Chen L; Winthrop K; Curtis JR
    Arthritis Res Ther; 2011; 13(5):R174. PubMed ID: 22024532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to Vaccinate Against Herpes Zoster and Its Associated Factors Across WHO Regions: Global Systematic Review and Meta-Analysis.
    Wang Q; Yang L; Li L; Liu C; Jin H; Lin L
    JMIR Public Health Surveill; 2023 Mar; 9():e43893. PubMed ID: 36892937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Projected risks and health benefits of vaccination against herpes zoster and related complications in US adults.
    Janusz CB; Anderson TC; Leidner AJ; Lee GM; Dooling K; Prosser LA
    Hum Vaccin Immunother; 2022 Nov; 18(5):2060668. PubMed ID: 35476029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
    Lu PJ; Euler GL; Jumaan AO; Harpaz R
    Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States.
    Lu A; Sun Y; Porco TC; Arnold BF; Acharya NR
    Ophthalmology; 2021 Dec; 128(12):1699-1707. PubMed ID: 33892049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of herpes zoster vaccination among Australian adults aged 65 and over.
    Ricks T; Trent MJ; MacIntyre CR
    Vaccine; 2022 Nov; 40(50):7182-7186. PubMed ID: 36336528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual incidence rates of herpes zoster among an immunocompetent population in the United States.
    Johnson BH; Palmer L; Gatwood J; Lenhart G; Kawai K; Acosta CJ
    BMC Infect Dis; 2015 Nov; 15():502. PubMed ID: 26546419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longterm Effectiveness of Herpes Zoster Vaccine among Patients with Autoimmune and Inflammatory Diseases.
    Yun H; Xie F; Baddley JW; Winthrop K; Saag KG; Curtis JR
    J Rheumatol; 2017 Jul; 44(7):1083-1087. PubMed ID: 28298565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
    Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
    J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
    Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R
    Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination among Medicare-fee-for service beneficiaries: Characteristics and predictors of vaccine receipt, 2014-2017.
    Shen AK; Warnock R; Selna W; MaCurdy TE; Chu S; Kelman JA
    Vaccine; 2019 Feb; 37(9):1194-1201. PubMed ID: 30683507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease.
    Tseng HF; Smith N; Harpaz R; Bialek SR; Sy LS; Jacobsen SJ
    JAMA; 2011 Jan; 305(2):160-6. PubMed ID: 21224457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.